Apyx Medical Corp (APYX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 7M 14M 21M Q1 '10: 5.6M Q2 '10: 5.9M Q3 '10: 6.5M Q4 '10: 6.2M Q1 '11: 6.2M Q2 '11: 6.8M Q3 '11: 6.3M Q4 '11: 6.2M Q1 '12: 6.7M Q2 '12: 7.4M Q3 '12: 6.7M Q4 '12: 6.8M Q1 '13: 5.7M Q2 '13: 6M Q3 '13: 5.8M Q4 '13: 6.1M Q1 '14: 6.5M Q2 '14: 6.9M Q3 '14: 6.8M Q4 '14: 7.5M Q1 '15: 6.1M Q2 '15: 7.3M Q3 '15: 7.8M Q4 '15: 8.3M Q1 '16: 7.8M Q2 '16: 9.3M Q3 '16: 10.1M Q4 '16: 9.5M Q1 '17: 8.4M Q2 '17: 9.8M Q3 '17: 2.7M Q4 '17: 3.7M Q1 '18: 3.4M Q2 '18: 3.7M Q3 '18: 3.7M Q4 '18: 5.8M Q1 '19: 5.6M Q2 '19: 6.6M Q3 '19: 7.6M Q4 '19: 8.4M Q1 '20: 5M Q2 '20: 4.3M Q3 '20: 7M Q4 '20: 11.5M Q1 '21: 8.6M Q2 '21: 11.2M Q3 '21: 11.8M Q4 '21: 16.8M Q1 '22: 12.5M Q2 '22: 10.3M Q3 '22: 9.1M Q4 '22: 12.6M Q1 '23: 12.1M Q2 '23: 13.6M Q3 '23: 12M Q4 '23: 14.7M Q1 '24: 10.2M Q2 '24: 12.1M Q3 '24: 11.5M Q4 '24: 14.2M Q1 '25: 9.4M Q2 '25: 11.4M Q3 '25: 12.9M Q4 '25: 19.2M Q1 '26: 12.5M Q2 '26: 13.9M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

0 5M 10M 15M Q1 '10: 2.3M Q2 '10: 2.3M Q3 '10: 2.7M Q4 '10: 2.7M Q1 '11: 2.4M Q2 '11: 3M Q3 '11: 2.6M Q4 '11: 2.6M Q1 '12: 2.8M Q2 '12: 2.9M Q3 '12: 2.9M Q4 '12: 2.8M Q1 '13: 2.2M Q2 '13: 2.2M Q3 '13: 2.2M Q4 '13: 2.6M Q1 '14: 2.8M Q2 '14: 1.9M Q3 '14: 1.9M Q4 '14: 2.4M Q1 '15: 2.7M Q2 '15: 3.1M Q3 '15: 3.2M Q4 '15: 3.5M Q1 '16: 3.3M Q2 '16: 4.7M Q3 '16: 5.1M Q4 '16: 4.8M Q1 '17: 4.2M Q2 '17: 5M Q3 '17: 1.9M Q4 '17: 2.7M Q1 '18: 2.2M Q2 '18: 2.5M Q3 '18: 2.5M Q4 '18: 3.6M Q1 '19: 3.6M Q2 '19: 4.7M Q3 '19: 5.3M Q4 '19: 5.6M Q1 '20: 3M Q2 '20: 2.1M Q3 '20: 4.7M Q4 '20: 7.7M Q1 '21: 5.9M Q2 '21: 7.5M Q3 '21: 8.1M Q4 '21: 12.2M Q1 '22: 8.2M Q2 '22: 6.9M Q3 '22: 5.8M Q4 '22: 8.2M Q1 '23: 7.6M Q2 '23: 9.3M Q3 '23: 8M Q4 '23: 8.9M Q1 '24: 5.9M Q2 '24: 7.5M Q3 '24: 7M Q4 '24: 9M Q1 '25: 5.7M Q2 '25: 7.1M Q3 '25: 8.3M Q4 '25: 12M Q1 '26: 7.9M Q2 '26: 8.9M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '10: -332K Q2 '10: -791K Q3 '10: -115K Q4 '10: -1.5M Q1 '11: 585K Q2 '11: 549K Q3 '11: 248K Q1 '12: 396K Q2 '12: 240K Q3 '12: 282K Q4 '12: 128K Q1 '13: -665K Q2 '13: -1.6M Q3 '13: -475K Q4 '13: -876K Q1 '14: 58K Q2 '14: -1.7M Q3 '14: -2.4M Q4 '14: -1.8M Q1 '15: -2.3M Q2 '15: -1.5M Q3 '15: -1.8M Q4 '15: -1.4M Q1 '16: -2M Q2 '16: -510K Q3 '16: -245K Q4 '16: -8.6M Q1 '17: -1.7M Q2 '17: -1.3M Q3 '17: -2.8M Q4 '17: -3.2M Q1 '18: -2.7M Q2 '18: -2.9M Q3 '18: -2.8M Q4 '18: -5.8M Q1 '19: -5.7M Q2 '19: -4.4M Q3 '19: -4.8M Q4 '19: -6M Q1 '20: -7.5M Q2 '20: -6.2M Q3 '20: -4.4M Q4 '20: -2.1M Q1 '21: -4.7M Q2 '21: -4M Q3 '21: -4M Q4 '21: -1.7M Q1 '22: -5.9M Q2 '22: -6M Q3 '22: -5.8M Q4 '22: -5.9M Q1 '23: -5.6M Q2 '23: -1.2M Q3 '23: -4.6M Q4 '23: -5.8M Q1 '24: -6.6M Q2 '24: -5.5M Q3 '24: -3.6M Q4 '24: -3M Q1 '25: -3.1M Q2 '25: -2.6M Q3 '25: -832K Q4 '25: 11K Q1 '26: -911K Q2 '26: -1.8M Q2 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-25M 0 25M 50M 75M Q2 '10: 56K Q3 '10: 4K Q4 '10: -1.4M Q1 '11: 492K Q2 '11: 429K Q3 '11: 63K Q4 '11: -875K Q1 '12: 187K Q2 '12: 152K Q3 '12: -7K Q4 '12: 285K Q1 '13: -409K Q2 '13: -1.1M Q3 '13: -341K Q4 '13: -5.1M Q1 '14: -9.6M Q2 '14: 251K Q3 '14: -2.7M Q4 '14: -5.5M Q1 '15: -876K Q2 '15: -1.5M Q3 '15: -1.6M Q4 '15: -1.4M Q1 '16: -1.9M Q2 '16: -519K Q3 '16: -965K Q4 '16: -8.1M Q1 '17: -1.7M Q2 '17: -1.3M Q3 '17: -1.2M Q4 '17: -824K Q1 '18: -935K Q2 '18: -2.9M Q3 '18: 68.5M Q4 '18: -3.3M Q1 '19: -5.6M Q2 '19: -4.3M Q3 '19: -4.4M Q4 '19: -5.4M Q1 '20: -2M Q2 '20: -4.7M Q3 '20: -3.7M Q4 '20: -1.5M Q1 '21: -4.9M Q2 '21: -4M Q3 '21: -4.2M Q4 '21: -2M Q1 '22: -5.9M Q2 '22: -5.4M Q3 '22: -5.8M Q4 '22: -6M Q1 '23: -3.5M Q2 '23: -994K Q3 '23: -4.6M Q4 '23: -9.6M Q1 '24: -7.6M Q2 '24: -6.6M Q3 '24: -4.7M Q4 '24: -4.6M Q1 '25: -4.2M Q2 '25: -3.8M Q3 '25: -2M Q4 '25: -1.3M Q1 '26: -2.1M Q2 '26: -3.2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 2.5M 5M 7.5M Q1 '10: 3.3M Q2 '10: 3.6M Q3 '10: 3.8M Q4 '10: 3.5M Q1 '11: 3.7M Q2 '11: 3.8M Q3 '11: 3.6M Q4 '11: 3.5M Q1 '12: 3.9M Q2 '12: 4.6M Q3 '12: 3.8M Q4 '12: 4M Q1 '13: 3.5M Q2 '13: 3.8M Q3 '13: 3.5M Q4 '13: 3.6M Q1 '14: 3.7M Q2 '14: 5.1M Q3 '14: 4.9M Q4 '14: 5M Q1 '15: 3.5M Q2 '15: 4.1M Q3 '15: 4.6M Q4 '15: 4.8M Q1 '16: 4.5M Q2 '16: 4.6M Q3 '16: 5M Q1 '17: 4.2M Q2 '17: 4.8M Q3 '17: 738K Q1 '18: 1.2M Q2 '18: 1.2M Q3 '18: 1.2M Q4 '18: 2.3M Q1 '19: 2.1M Q2 '19: 2M Q3 '19: 2.3M Q4 '19: 2.8M Q1 '20: 2M Q2 '20: 2.2M Q3 '20: 2.2M Q4 '20: 3.8M Q1 '21: 2.8M Q2 '21: 3.7M Q3 '21: 3.8M Q4 '21: 4.7M Q1 '22: 4.3M Q2 '22: 3.4M Q3 '22: 3.4M Q4 '22: 4.4M Q1 '23: 4.6M Q2 '23: 4.3M Q3 '23: 4M Q4 '23: 5.7M Q1 '24: 4.3M Q2 '24: 4.7M Q3 '24: 4.5M Q4 '24: 5.3M Q1 '25: 3.8M Q2 '25: 4.3M Q3 '25: 4.6M Q4 '25: 7.2M Q1 '26: 4.6M Q2 '26: 5M Q4 '11 Q4 '13 Q4 '15 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '10: -621K Q1 '11: 737K Q2 '11: 1.5M Q3 '11: -72K Q4 '11: -248K Q1 '12: -486K Q2 '12: 940K Q3 '12: -300K Q4 '12: 11K Q1 '13: -253K Q2 '13: -1M Q3 '13: 78K Q4 '13: -1.3M Q1 '14: -1M Q2 '14: -264K Q3 '14: 698K Q4 '14: 198K Q1 '15: -1.8M Q2 '15: -2.3M Q3 '15: -644K Q4 '15: -1M Q1 '16: -2.3M Q2 '16: -113K Q3 '16: 87K Q4 '16: -544K Q1 '17: -2.8M Q2 '17: -1.1M Q3 '17: -541K Q4 '17: 731K Q1 '18: -1.1M Q2 '18: -573K Q3 '18: -1.2M Q4 '18: -18M Q1 '19: -5.1M Q2 '19: -5.6M Q3 '19: -4.5M Q4 '19: -3.3M Q1 '20: -7.4M Q2 '20: -5M Q3 '20: -2.6M Q4 '20: -1M Q1 '21: -2.1M Q2 '21: -5M Q3 '21: -3.6M Q4 '21: 214K Q1 '22: -4.5M Q2 '22: -5.9M Q3 '22: -5.4M Q4 '22: -4.5M Q1 '23: -1.9M Q2 '23: -4.9M Q3 '23: 3.7M Q4 '23: -2.2M Q1 '24: -6.3M Q2 '24: -4.3M Q3 '24: -4.4M Q4 '24: -2.9M Q1 '25: -702K Q2 '25: -1.2M Q3 '25: -3.5M Q4 '25: -2.5M Q1 '26: -572K Q2 '26: -3.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '10: -684K Q1 '11: 662K Q2 '11: 1.3M Q3 '11: -270K Q4 '11: -331K Q1 '12: -729K Q2 '12: 896K Q3 '12: -462K Q4 '12: -293K Q1 '13: -384K Q2 '13: -1.2M Q3 '13: -46K Q4 '13: -1.5M Q1 '14: -1.1M Q2 '14: -353K Q3 '14: 543K Q4 '14: -113K Q1 '15: -2M Q2 '15: -2.5M Q3 '15: -786K Q1 '16: -2.3M Q2 '16: -133K Q3 '16: -54K Q4 '16: -648K Q1 '17: -2.9M Q2 '17: -1.2M Q3 '17: -821K Q4 '17: 538K Q1 '18: -1.2M Q2 '18: -766K Q3 '18: -1.3M Q4 '18: -18.2M Q1 '19: -5.2M Q2 '19: -6M Q3 '19: -5.1M Q4 '19: -3.5M Q1 '20: -7.5M Q2 '20: -5.1M Q3 '20: -2.6M Q4 '20: -1.4M Q1 '21: -2.2M Q2 '21: -5M Q3 '21: -3.8M Q4 '21: -118K Q1 '22: -4.8M Q2 '22: -6.3M Q3 '22: -5.5M Q4 '22: -4.7M Q1 '23: -2M Q2 '23: -5M Q3 '23: 3.5M Q4 '23: -2.3M Q1 '24: -6.4M Q2 '24: -4.6M Q3 '24: -4.6M Q4 '24: -3.2M Q1 '25: -757K Q2 '25: -1.5M Q3 '25: -4.1M Q4 '25: -2.8M Q1 '26: -632K Q2 '26: -3.6M Q1 '12 Q1 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '10: 17.4K Q3 '10: 17.6M Q1 '11: 17.6K Q2 '11: 17.8M Q3 '11: 17.8M Q1 '12: 17.8M Q2 '12: 17.8K Q3 '12: 17.6K Q1 '13: 17.6K Q2 '13: 17.7K Q3 '13: 17.7K Q1 '14: 17.7K Q2 '14: 21.2M Q3 '14: 17.8M Q1 '15: 20.5M Q2 '15: 24.4K Q3 '15: 27.1K Q1 '16: 27.1M Q2 '16: 27.1M Q3 '16: 27.1M Q1 '17: 30.9M Q2 '17: 30.9M Q3 '17: 31.1M Q1 '18: 32.9M Q2 '18: 32.9M Q3 '18: 34.9M Q2 '20: 34.2M Q3 '20: 34.2M Q1 '21: 34.3M Q2 '21: 34.3M Q3 '21: 34.3M Q1 '22: 34.4M Q2 '22: 34.5M Q3 '22: 34.6M Q1 '23: 34.6M Q2 '23: 34.6M Q3 '23: 34.6M Q1 '24: 34.6M Q2 '24: 34.6M Q3 '24: 34.6M Q1 '25: 40.7M Q2 '25: 40.7M Q3 '25: 40.7M Q1 '26: 43.7M Q2 '26: 43.9M Q1 '11 Q1 '13 Q1 '15 Q1 '17 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-105.00 -70.00 -35.00 0.00 35.00 70.00 105.00 Q4 '10: -0.09 Q1 '12: -0.02 Q3 '16: -0.18 Q4 '16: -0.15 Q1 '17: -0.14 Q2 '17: -0.16 Q3 '17: -0.16 Q4 '17: -0.17 Q1 '18: -0.14 Q2 '19: -98.34 Q3 '19: -100.43 Q4 '19: -0.59 Q1 '20: -0.48 Q2 '20: -0.49 Q3 '20: -0.47 Q4 '20: -0.36 Q1 '21: -0.44 Q2 '21: -0.42 Q3 '21: -0.43 Q4 '21: -0.44 Q1 '22: -0.47 Q2 '22: -0.51 Q3 '22: -0.56 Q4 '22: -0.67 Q1 '23: -0.60 Q2 '23: -0.47 Q3 '23: -0.43 Q4 '23: -0.54 Q1 '24: -0.66 Q2 '24: -0.82 Q3 '24: -0.83 Q4 '24: -0.67 Q1 '25: -0.55 Q2 '25: -0.45 Q3 '25: -0.36 Q4 '25: -0.27 Q1 '26: -0.22 Q2 '26: -0.20 Q3 '16 Q4 '17 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.